UBT251 Injection 6.0 mg and UBT251 Injection Placebo for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 14 Mar 2025: Trial started, NCT07177469
  2. 17 Sep 2025: Trial registered, NCT07177469

The trials

NCT07177469: UBT251 Injection Phase II Study (Overweight or Obesity)

State
Completed
Phase
Phase 2
People
205 taking part
Started
14 Mar 2025
Primary completion
22 Oct 2025
Arms
UBT251 Injection 6.0 mg
Results
None posted
  1. 14 Mar 2025: Trial started
  2. 17 Sep 2025: Trial registered
  3. 19 Nov 2025: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.